<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/164</identifier>
				<datestamp>2024-10-30T18:55:39Z</datestamp>
				<setSpec>aavptbiennial:S3</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Novel Drug Delivery Sytems</dc:title>
	<dc:creator xml:lang="en">McGinity, James W.</dc:creator>
	<dc:subject xml:lang="en">drug delivery system</dc:subject>
	<dc:subject xml:lang="en">pharmaceutical science</dc:subject>
	<dc:subject xml:lang="en">cost-efficiency</dc:subject>
	<dc:subject xml:lang="en">controlled drug release</dc:subject>
	<dc:description xml:lang="en">During the past decade a new era of science and technology has emerged in pharmaceutical research aimed at the development of novel or advanced drug delivery systems. The development of novel delivery systems for veterinary medicine is generally more complex than for human dosage forms due to the variety of animal species treated with differing gastrointestinal and anatomical features. As a result, a close working relationship between veterinarians and pharmaceutical scientists is essential for the development of a successful product. The emphasis in this manuscript will be on systems for human use; however, similar technology and scientific principles are employed in drug delivery systems for animals.
For human and animal health novel delivery systems, common concerns exist in areas of cost-efficient treatment, "patient compliance" and optimum drug delivery and bioavailability. Ideally, controlled drug release entails carefully programming the output of a chemical from a physicochemical system such that drug release can be activated on demand.</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>1984-04-25</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/164</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; Fourth Symposium; 70-97</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/164/156</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1984 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
